ORYZON Announces First‑Patient‑In (FPI) in RESTORE Phase Ib Trial of Iadademstat in Sickle Cell Disease

Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat’s ability to raise fetal hemoglobin (HbF) in adult patients ...

Oryzon Genomics, S.A.: ORYZON Announces First-Patient-In (FPI) in RESTORE Phase Ib Trial of Iadademstat in Sickle Cell Disease

Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat's ability to raise fetal hemoglobin (HbF) in adult patients with SCDIadademstat has demonstrated a favorable safet ...
ScienceAlert on MSN

Chimps Can Revise Their Beliefs When Shown New Evidence, Study Finds

Chimpanzees can change their minds when the facts no longer support their previous beliefs – a rational level of thinking ...